Exendin-4 derivative and solid phase chemical synthesis thereof
A technology for synthesizing derivatives and polypeptides, applied in the field of bioengineering, can solve the problems of decreased activity, low yield, complicated preparation process, etc., and achieve the effects of fewer production steps, short production cycle, and fast and simple process
Inactive Publication Date: 2009-06-24
EAST CHINA NORMAL UNIV
View PDF0 Cites 10 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, GLP-1 will be rapidly degraded and inactivated by dipeptidyl peptidase IV (DPPIV) in vivo, and its half-life is less than 2 minutes, so its clinical application is limited.
[0006] Studies have shown that the C-terminal 9 peptide of Exendin-4 plays an important role in its activity, so the above-mentioned truncated Exendin-4 will have different degrees of decline in activity compared with the original peptide; although the method of changing the amino acid species in the peptide chain is beneficial Production, but the effect of improving stability and prolonging the drug effect time in vivo is not significant, such as: the Exendin-4 analog obtained by replacing Met with Leu at the 14th position and Trp with Phe at the 25th position and Exendin -4 Compared with the in vivo drug effect time, it is not prolonged; the preparation process of Exendin derivatives modified with polyethylene glycol is more complicated, the product separation and purification are difficult, and the yield is very low, which is not conducive to industrial production
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0045] Example 1 The amino acid sequence of the Exendin-4 derivative provided by the present invention, such as Seq ID No.2, wherein Xaa40=Cys.
Embodiment 2
[0046] Example 2 The amino acid sequence of the Exendin-4 derivative provided by the present invention, such as Seq ID No.3, wherein Xaa40=Cys, Xaa41=Gly.
Embodiment 3
[0047] Example 3 The amino acid sequence of the Exendin-4 derivative provided by the present invention, such as Seq ID No.3, wherein Xaa40=Gly, Xaa41=Cys.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more
Abstract
The invention discloses an Exendin-4 derivant with Exendin-4 activity and preparation and application thereof, belonging to the technical field of biological engineering. The molecular structural formula of the derivant is any one of the following structures: Exendin-4(1-39)-Xaa40(Seq ID No.2), Exendin-4(1-39)-Xaa40-Xaa41(Seq ID No.3), Exendin-4 (1-39)-Xaa40-Xaa41-Xaa42(Seq ID No.4), Exendin-4(1-30)-Xaa31(Seq ID No.6), Exendin-4(1-30)-Xaa31-Xaa32(Seq ID No.7) and/or Exendin-4 (1-30)-Xaa31-Xaa32-Xaa33(Seq ID No.8); wherein, Xaa40, Xaa41, Xaa42, Xaa31, Xaa32 and Xaa33 are respectively any amino acid of Cys, Ala, Gly, His, Ser and Thr. The Exendin-4 derivant has the advantage that the derivant has longer in-vivo drug effect time than Exendin-4. Solid phase chemosynthesis is adopted to prepare the Exendin-4 derivant, so that production steps are few and production cost is low. The Exendin-4 derivant is particularly suitable for preparing the active ingredient of drugs for curing diabetes.
Description
technical field [0001] The invention relates to an Exendin-4 derivative with Exendin-4 activity and its solid-phase chemical synthesis, belonging to the technical field of bioengineering. Background technique [0002] Diabetes is one of the three major diseases that threaten human health. The incidence rate is extremely high, and it is increasing year by year. Its obvious clinical symptoms are that the glucose content in blood and urine exceeds the normal range, accompanied by "three more and one less", that is, eating more, Polydipsia, polyuria and weight loss. Among them, type II diabetes patients account for more than 90%. For a long time, people have mainly used drugs such as sulfonylureas and biguanides to treat type II diabetes, but these drugs have relatively large side effects, and long-term use can lead to pancreatic β-cell failure. A glucagon-like peptide 1 (GLP-1) secreted by the human body can stimulate insulin secretion when blood sugar is high, thereby lowerin...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/435C07K1/20C07K1/06C07K1/04A61K38/17A61P3/10
Inventor 汪洋吴自荣顾娟黄静孙昭
Owner EAST CHINA NORMAL UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap